Acetazolamide Capsule
Product Images NDC 70710-1591

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 70710-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 01)

FDA Label Image

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 02)

Figure (47f76d7e Da1c 40ba A97b 001319d4a6be 02)
AcetaZOLAMIDE is a drug that comes in extended-release capsules. The recommended usage and other important information regarding prescribing are listed in the package insert. These capsules should be stored at controlled room temperature and kept in a tight container. The manufacturer of the drug is Calila Healthcare Ltd., based in Ahmedabad, India, while Rxonly Pharmaceuticals (USA) Inc. distributes the drug in 100-capsule packages from Pennington, NJ. It is important to store this drug out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.